The evaluation of the possibility of the estimation the amount of hemagglutininin in the final lots of inactivated adjuvanted influenza vaccines
Introduction. The main quality indicator for inactivated influenza vaccines is their potency (the amount of hemagglutinin). The potency test for the influenza vaccine with the SOVIDON adjuvant is carried out in a trivalent bulk vaccine before the addition of the adjuvant. This approach has its fair...
Saved in:
| Main Authors: | Aleksey Y. Butirskiy, Elena N. Morozova, Karine A. Sarkisyan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Central Research Institute for Epidemiology
2025-03-01
|
| Series: | Вопросы вирусологии |
| Subjects: | |
| Online Access: | https://virusjour.crie.ru/jour/article/viewFile/16708/958 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Analysis of Approaches to Assess the Quality of Inactivated Influenza Vaccines: Regulatory Requirements in the Russian Federation and European Union
by: L. M. Khantimirova, et al.
Published: (2021-01-01) -
Computationally Optimized Hemagglutinin Proteins Adjuvanted with Infectimune<sup>®</sup> Generate Broadly Protective Antibody Responses in Mice and Ferrets
by: James D. Allen, et al.
Published: (2024-12-01) -
Inactivated influenza virus vaccines expressing COBRA hemagglutinin elicited broadly reactive, long-lived protective antibodies
by: Hua Shi, et al.
Published: (2024-12-01) -
Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses
by: Anthony L. Desbien, et al.
Published: (2013-06-01) -
Development of an Influenza/COVID-19 Combination mRNA Vaccine Containing a Novel Multivalent Antigen Design That Enhances Immunogenicity of Influenza Virus B Hemagglutinins
by: Elena Thornhill-Wadolowski, et al.
Published: (2025-06-01)